Anne Kathrin T.
- Country
- Germany
- Department
- 1906: Medizinische Klinik und Poliklinik III (Rheumatologie)
Research Overview
- Open-Label Extension Study Evaluating Long-Term Safety and Tolerability of Subcutaneous Secukinumab in Patients with Polymyalgia Rheumatica
- A randomized, parallel-group, double-blind, placebo-controlled, multicenter Phase III trial to evaluate efficacy and safety of secukinumab administered subcutaneously versus placebo, in combination with a glucocorticoid taper regimen, in patients with polymyalgia rheumatica (PMR)
Data & Insights
Has run more than one trial at 55 of 77 partner sites.
Specializations
Rheumatic Disease Specialization
This investigator focuses on systemic autoimmune rheumatic diseases, particularly their pulmonary manifestations. Their expertise extends to evaluating innovative therapeutic approaches for patients affected by these complex conditions.
- Autoimmune Disease Management
- Rheumatic Disease Complications
Pulmonary Medicine
The investigator specializes in interstitial lung diseases, with particular attention to those associated with rheumatic conditions. Their work involves advanced imaging techniques including quantitative high-resolution computed tomography.
- Lung Fibrosis Assessment
- Pulmonary Imaging Analysis
Therapeutic Focus
Their research centers on emerging treatments for SARD-ILD, exploring novel therapeutic agents for managing lung complications in rheumatic diseases. The investigator evaluates treatment outcomes through sophisticated quantitative assessment methods.
- Innovative Treatment Evaluation
- Disease Progression Monitoring
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.